VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 210 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,096,800 | +5.4% | 85,479 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $1,989,096 | -8.1% | 85,479 | 0.0% | 0.01% | -12.5% |
Q4 2022 | $2,163,473 | +20.3% | 85,479 | -8.3% | 0.01% | +14.3% |
Q3 2022 | $1,798,000 | -24.3% | 93,256 | 0.0% | 0.01% | -22.2% |
Q2 2022 | $2,375,000 | +7.7% | 93,256 | +8.7% | 0.01% | +28.6% |
Q1 2022 | $2,206,000 | -38.6% | 85,760 | 0.0% | 0.01% | -30.0% |
Q4 2021 | $3,591,000 | +41.4% | 85,760 | +47.0% | 0.01% | +25.0% |
Q3 2021 | $2,539,000 | -4.6% | 58,339 | +3.6% | 0.01% | -11.1% |
Q2 2021 | $2,661,000 | – | 56,290 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |